THE ORGANIZATION AND EXPRESSION OF CYSTATIN GENES

胱抑素基因的组织和表达

基本信息

项目摘要

The overall goal of this proposal is to understand mechanisms of gene expression of cystatins, particularly salivary cystatins, with emphasis on cis- and trans-acting elements that modulate gene transcription. Cystatins are cysteine proteinase inhibitors that are thought to be involved in the protective mechanisms against endogenous cysteine proteinases that are released during inflammation or tissue necrosis. The cystatins are grouped into three families on the basis of their molecular structure. Family 1 cystatins are found mainly intracellulary and are present as constitutive components of many rat tissues. Family 2 cystatins are mainly present in extracellular fluids. Kininogens are family 3 cystatins, present mainly in the plasma. As opposed to family 1 cystatins, which are constitutive components of rat tissues, family 2 cystatin is not detected in normal rat tissues, but is induced in submandibular glands of rats treated with beta-agonist isoproterenol. Although family 3 cystatins (kininogens) also act as acute-phase reactants in rat plasma, they are also present in the normal plasma. These observations suggest that biosynthesis and secretion of the three cystatins may have different mechanisms for regulation. Since three cystatin families have presumably evolved from a single primordial sequence, it appears that they have acquired distinct modulator responsive control elements. The aim of the proposed research is to study the differential expression of three cystatins at the transcriptional level and to analyze the cis-acting transcriptional elements of cystatin genes. More precisely, CDNA clones corresponding to these cystatins will be isolated and used to study the transcriptional control. Genomic clones for family 1 (non inducible, constitutive) and family 2 (inducible) cystatins will be isolated using respective CDNA probes, restriction mapped and pertinent regions sequenced. Genomic structure of family 3 cystatin (kininogen) has been fairly will characterized. We then intend to locate the potential regulatory regions (cis-acting elements) of the rat salivary cystatin (family 2) gene promotor responsible for either the basal-level and/or high-level transcription of this gene. This will be accomplished by joining the 5'- flanking regions of the cystatin gene and series of deletion mutations to a CAT reporter gene and assaying for changes in reporter gene expression in a variety of cells. Lastly, we propose to study DNA- protein interactions using the gel mobility shift assay in order to identify the trans-acting factors responsible for regulation of rat salivary cystatin gene expression.
这项提案的总体目标是了解基因的机制, 胱抑素,特别是唾液胱抑素的表达, 调节基因转录的顺式和反式作用元件。 胱抑素是半胱氨酸蛋白酶抑制剂, 是 参与对抗内源性半胱氨酸的保护机制 在炎症或组织坏死期间释放的蛋白酶。 半胱氨酸蛋白酶抑制剂根据其功能分为三个家族。 分子结构家族1胱抑素主要存在于细胞内 并作为许多大鼠组织的组成成分存在。家族2 胱抑素主要存在于细胞外液中。激肽原是 家族3胱抑素,主要存在于血浆中。相对于家庭1 半胱氨酸蛋白酶抑制剂,其是大鼠组织的组成成分,家族2 在正常大鼠组织中未检测到半胱氨酸蛋白酶抑制剂,但在 用β-激动剂异丙肾上腺素处理的大鼠的下颌下腺。 虽然家族3半胱氨酸蛋白酶抑制剂(激肽原)也可作为急性期 反应物在大鼠血浆中,它们也存在于正常血浆中。 这些观察结果表明,这三种细胞的生物合成和分泌 半胱氨酸蛋白酶抑制剂可能具有不同的调节机制。自从三 半胱氨酸蛋白酶抑制剂家族可能是从一个单一的原始 序列,似乎他们已经获得了不同的调制器, 响应控制元件。拟议研究的目的是 研究三种半胱氨酸蛋白酶抑制剂在大鼠肝组织中的差异表达, 转录水平,并分析顺式作用的转录 半胱氨酸蛋白酶抑制剂基因的元件。更准确地说,对应于 这些半胱氨酸蛋白酶抑制剂将被分离并用于研究转录 控制家族1的基因组克隆(非诱导型,组成型)和 家族2(诱导型)半胱氨酸蛋白酶抑制剂将使用各自的cDNA 探针、限制性酶切图谱和相关区域测序。基因组 家族3半胱氨酸蛋白酶抑制剂(激肽原)结构已经相当令人满意 表征了然后,我们打算定位潜在的监管区域, 大鼠唾液半胱氨酸蛋白酶抑制剂(家族2)基因的顺式作用元件 负责基础水平和/或高水平的促进者 这个基因的转录。这将通过加入5'- 半胱氨酸蛋白酶抑制剂基因的侧翼区域和一系列缺失突变 与CAT报告基因连接并测定报告基因中的变化 在多种细胞中表达。最后,我们建议研究DNA- 使用凝胶迁移率变动测定蛋白质相互作用, 确定负责调节大鼠的反式作用因子 唾液胱抑素基因表达。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GURRINDER S BEDI其他文献

GURRINDER S BEDI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GURRINDER S BEDI', 18)}}的其他基金

Association of Caries and Salivary Analytes
龋齿和唾液分析物协会
  • 批准号:
    6841646
  • 财政年份:
    2004
  • 资助金额:
    $ 11.06万
  • 项目类别:
Association of Caries and Salivary Analytes
龋齿和唾液分析物协会
  • 批准号:
    6564063
  • 财政年份:
    2002
  • 资助金额:
    $ 11.06万
  • 项目类别:
CARBOHYDRATE-BASED PEPTIDOMIMETICS TO PREVENT CANDIDIAS
基于碳水化合物的拟肽预防念珠菌
  • 批准号:
    2904896
  • 财政年份:
    2000
  • 资助金额:
    $ 11.06万
  • 项目类别:
CARBOHYDRATE-BASED PEPTIDOMIMETICS TO PREVENT CANDIDIAS
基于碳水化合物的拟肽预防念珠菌
  • 批准号:
    6362941
  • 财政年份:
    2000
  • 资助金额:
    $ 11.06万
  • 项目类别:
Association of Caries and Salivary Analytes
龋齿和唾液分析物协会
  • 批准号:
    6287850
  • 财政年份:
    1995
  • 资助金额:
    $ 11.06万
  • 项目类别:
ORGANIZATION AND EXPRESSION OF CYSTATIN GENES
半胱氨酸蛋白酶抑制剂基因的组织和表达
  • 批准号:
    3223487
  • 财政年份:
    1992
  • 资助金额:
    $ 11.06万
  • 项目类别:
ORGANIZATION AND EXPRESSION OF CYSTATIN GENES
半胱氨酸蛋白酶抑制剂基因的组织和表达
  • 批准号:
    2130701
  • 财政年份:
    1992
  • 资助金额:
    $ 11.06万
  • 项目类别:
THE ORGANIZATION AND EXPRESSION OF CYSTATIN GENES
胱抑素基因的组织和表达
  • 批准号:
    3223489
  • 财政年份:
    1992
  • 资助金额:
    $ 11.06万
  • 项目类别:
ORGANIZATION AND EXPRESSION OF CYSTATIN GENES
半胱氨酸蛋白酶抑制剂基因的组织和表达
  • 批准号:
    3509665
  • 财政年份:
    1991
  • 资助金额:
    $ 11.06万
  • 项目类别:
REGULATION OF INDUCIBLE RAT SALIVARY CYSTATIN
诱导性大鼠唾液胱抑素的调节
  • 批准号:
    3425481
  • 财政年份:
    1990
  • 资助金额:
    $ 11.06万
  • 项目类别:

相似海外基金

Acute phase protein and cachexia on adaptive immunity in thoracic malignancy
急性期蛋白和恶病质对胸部恶性肿瘤适应性免疫的影响
  • 批准号:
    21K15584
  • 财政年份:
    2021
  • 资助金额:
    $ 11.06万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute phase protein as biomarkers of disease in livestock and aquaculture
急性期蛋白作为畜牧业和水产养殖疾病的生物标志物
  • 批准号:
    BB/M022021/1
  • 财政年份:
    2015
  • 资助金额:
    $ 11.06万
  • 项目类别:
    Research Grant
Disease specific modification and glycosylation dynamism of acute phase protein in severe disease conditions
严重疾病条件下急性期蛋白的疾病特异性修饰和糖基化动态
  • 批准号:
    15K07745
  • 财政年份:
    2015
  • 资助金额:
    $ 11.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The acute-phase protein serum amyloid A1 plays a key role in inflammation induced skeletal muscle atrophy in critically ill patients.
急性时相蛋白血清淀粉样蛋白 A1 在危重患者炎症引起的骨骼肌萎缩中发挥关键作用。
  • 批准号:
    249567787
  • 财政年份:
    2014
  • 资助金额:
    $ 11.06万
  • 项目类别:
    Research Grants
Acute phase protein as biomarkers of disease in livestock
急性期蛋白作为家畜疾病的生物标志物
  • 批准号:
    BB/M015858/1
  • 财政年份:
    2014
  • 资助金额:
    $ 11.06万
  • 项目类别:
    Research Grant
Acute Phase Protein Effects in Cellular Mechanisms of Microvascular Endothelium
急性期蛋白对微血管内皮细胞机制的影响
  • 批准号:
    7459156
  • 财政年份:
    2008
  • 资助金额:
    $ 11.06万
  • 项目类别:
Acute Phase Protein Effects in Cellular Mechanisms of Microvascular Endothelium
急性期蛋白对微血管内皮细胞机制的影响
  • 批准号:
    7786540
  • 财政年份:
    2008
  • 资助金额:
    $ 11.06万
  • 项目类别:
TRANSLATIONAL RESEARCH ON A MODEL OF GLYCAN CHAIN MODIFICATION OF ACUTE PHASE PROTEIN
急性期蛋白聚糖链修饰模型的转化研究
  • 批准号:
    19580370
  • 财政年份:
    2007
  • 资助金额:
    $ 11.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Changes on glycosylation and serum levels of acute phase protein in severe viral infection.
重症病毒感染时急性期蛋白糖基化及血清水平的变化
  • 批准号:
    17580280
  • 财政年份:
    2005
  • 资助金额:
    $ 11.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Ceramide and acute phase protein elevation during aging
衰老过程中神经酰胺和急性期蛋白升高
  • 批准号:
    8131944
  • 财政年份:
    2002
  • 资助金额:
    $ 11.06万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了